Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer
Br J Surg
.
2022 May 16;109(6):489-492.
doi: 10.1093/bjs/znac050.
Authors
Anai Kothari
1
,
Michael G White
2
,
Oliver Peacock
2
,
Harmeet Kaur
3
,
Sarah M Palmquist
3
,
Nancy You
2
,
Melissa Taggart
4
,
Usama Salem
3
,
Michael Overman
5
,
Scott Kopetz
5
,
George J Chang
2
Affiliations
1
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2
Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
3
Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
4
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
5
Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
PMID:
35576377
DOI:
10.1093/bjs/znac050
No abstract available
MeSH terms
Colorectal Neoplasms* / genetics
Colorectal Neoplasms* / pathology
Colorectal Neoplasms* / therapy
DNA Mismatch Repair / genetics
Humans
Immunotherapy
Microsatellite Instability*
Neoadjuvant Therapy